Scott Thomas Smith

CIK: 0001965550

Transaction Breakdown

Open Market Buys (P)2 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ASND

Ascendis Pharma A/S

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

ASND
Ascendis Pharma A/S
Jun 2, 2026
Purchase(P)
Direct
100 shares at avg. $219.00$22K
ASND
Ascendis Pharma A/S
May 29, 2026
Purchase(P)
Direct
250 shares at avg. $223.32$56K

		Type	Shares	Price		Ownership
Jun 2, 2026	ASND Ascendis Pharma A/S	Purchase(P)	100	$219.00	$21,900	Direct
May 29, 2026	ASND Ascendis Pharma A/S	Purchase(P)	250	$223.32	$55,830	Direct

1-2 of 2 transactions

About SMITH SCOTT THOMAS

SMITH SCOTT THOMAS (SEC CIK 0001965550) files insider reports with the SEC as EVP & Chief Financial Officer of Ascendis Pharma A/S (ASND).

Signal8 holds 4 ownership filings by SMITH SCOTT THOMAS (2 Form 3, 2 Form 4), filed between Mar 18, 2026 and Jun 2, 2026. Those filings report 2 transactions, from May 29, 2026 to Jun 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on SMITH SCOTT THOMAS's filings is in HELLERUP.

Recent filings by SMITH SCOTT THOMAS

Jun 2, 2026: Open-market purchase of ASND shares (Form 4, code P).
May 29, 2026: Open-market purchase of ASND shares (Form 4, code P).

Other insiders filing for Ascendis Pharma A/S (ASND)

How to read Form 4 transaction codes